CoQ10: safety and interactions

CoQ10 tolerability and combinations with warfarin, insulin and cancer treatment.

Key points

  • Mild insomnia and digestive disturbances have been reported with CoQ10. If these symptoms bother you after starting it, discuss the supplement with a healthcare professional. [1] See the evidence 1
  • CoQ10 may interact with warfarin; the size of the effect in an individual is unknown. Before starting or stopping CoQ10, agree INR monitoring with your doctor. [1] [2] See the evidence 1
  • CoQ10 may also interact with insulin or some anticancer treatments. Before starting the supplement, discuss it with your treating doctor or oncologist. [1] See the evidence 1 2

Practical guide

Check the conclusions and whether they apply to your situation.

Medicines and individual circumstances matter when choosing a supplement.

Key points

Why these conclusions

Tolerability and interactions

In a small crossover study of 24 patients on stable warfarin, 21 of whom completed the study, no significant difference in required warfarin dose was found between CoQ10 and placebo with INR monitoring. This does not rule out a possible interaction in an individual. [3]

A trial in high-risk pregnant women from week 20 does not establish CoQ10 safety in early pregnancy, during lactation or in children. [4]

Mild insomnia and gastrointestinal disturbances are reported; short RCTs do not establish rare or long-term risks. [1]

A published EudraVigilance analysis reported 271 adverse reaction reports involving CoQ10, including serious reports; without a user denominator, they do not establish causation or frequency. [5]

NCCIH warns of potential interactions; individual reports and a small RCT cannot reliably establish the size or direction of an effect in an individual. [1] [3]

A limited RCT in high-risk women from week 20 does not establish safety at all stages of pregnancy or in children; data in lactation and children are insufficient. [6] [4]

Warfarin: CoQ10 may interact with warfarin and alter its anticoagulant effect; the magnitude in an individual is unknown. Before starting or stopping CoQ10, discuss it with the doctor managing warfarin and agree INR monitoring. [1] [2]

Insulin: CoQ10 may interact with insulin; the source does not establish the magnitude or direction of the effect. Before starting CoQ10, discuss it with the doctor managing your insulin treatment. [1]

Some anticancer medicines: CoQ10 may be incompatible with some cancer treatments. Discuss the supplement with your oncologist before starting it. [1]

In a small crossover study of 24 patients on stable warfarin, 21 of whom completed the study, no significant difference in required warfarin dose was found between CoQ10 and placebo with INR monitoring. This does not rule out a possible interaction in an individual.

ParameterData
ResultWith INR monitoring, no significant difference in required warfarin dose was found between CoQ10 and placebo. Geometric mean warfarin dose was 36.5 versus 36.0 mg/week, respectively.
Participants24 patients on stable warfarin, 21 completed
Form100 mg/day CoQ10
Dose100 mg/day CoQ10
Dose basis100 mg/day CoQ10
ComparatorPlacebo and separate ginkgo; double-blind crossover comparison
Duration4 weeks per condition, 2-week intervals
Confidence1/4: 21 of 24 completed the crossover trial. No grounds for a separate downgrade. INR was maintained by dose adjustment; risk without monitoring was not assessed. Small sample and four weeks per condition. No specific data for a separate downgrade.
Evidence base1 crossover trial
Sources[3]

A trial in high-risk pregnant women from week 20 does not establish CoQ10 safety in early pregnancy, during lactation or in children.

A trial in high-risk pregnant women from week 20 does not establish CoQ10 safety in early pregnancy, during lactation or in children. [4]

Mild insomnia and gastrointestinal disturbances are reported; short RCTs do not establish rare or long-term risks.

Mild insomnia and gastrointestinal disturbances are reported; short RCTs do not establish rare or long-term risks. [1]

A published EudraVigilance analysis reported 271 adverse reaction reports involving CoQ10, including serious reports; without a user denominator, they do not establish causation or frequency.

A published EudraVigilance analysis reported 271 adverse reaction reports involving CoQ10, including serious reports; without a user denominator, they do not establish causation or frequency. [5]

NCCIH warns of potential interactions; individual reports and a small RCT cannot reliably establish the size or direction of an effect in an individual.

NCCIH warns of potential interactions; individual reports and a small RCT cannot reliably establish the size or direction of an effect in an individual. [1] [3]

A limited RCT in high-risk women from week 20 does not establish safety at all stages of pregnancy or in children; data in lactation and children are insufficient.

A limited RCT in high-risk women from week 20 does not establish safety at all stages of pregnancy or in children; data in lactation and children are insufficient. [6] [4]

Warfarin: CoQ10 may interact with warfarin and alter its anticoagulant effect; the magnitude in an individual is unknown. Before starting or stopping CoQ10, discuss it with the doctor managing warfarin and agree INR monitoring.

Warfarin: CoQ10 may interact with warfarin and alter its anticoagulant effect; the magnitude in an individual is unknown. Before starting or stopping CoQ10, discuss it with the doctor managing warfarin and agree INR monitoring. [1] [2]

Insulin: CoQ10 may interact with insulin; the source does not establish the magnitude or direction of the effect. Before starting CoQ10, discuss it with the doctor managing your insulin treatment.

Insulin: CoQ10 may interact with insulin; the source does not establish the magnitude or direction of the effect. Before starting CoQ10, discuss it with the doctor managing your insulin treatment. [1]

Some anticancer medicines: CoQ10 may be incompatible with some cancer treatments. Discuss the supplement with your oncologist before starting it.

Some anticancer medicines: CoQ10 may be incompatible with some cancer treatments. Discuss the supplement with your oncologist before starting it. [1]

More details

How to coordinate intake

If taking warfarin, discuss starting or stopping CoQ10 with the doctor managing treatment and agree INR monitoring. [1] [2]

Sources

  1. Coenzyme Q10 | NCCIH. https://www.nccih.nih.gov/health/coenzyme-q10
  2. Coenzyme Q10 | Linus Pauling Institute | Oregon State University. https://lpi.oregonstate.edu/mic/dietary-factors/coenzyme-Q10
  3. [Effect of Coenzyme Q10 and Ginkgo biloba on warfarin dosage in patients on long-term warfarin treatment. A randomized, double-blind, placebo-controlled cross-over trial]. https://pubmed.ncbi.nlm.nih.gov/12772396/
  4. Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia. https://pubmed.ncbi.nlm.nih.gov/19154996/
  5. Comparative Analysis of L-Carnitine and Coenzyme Q10 Adverse Reaction Reports Using the EudraVigilance Database: Implications for Health and Sports Supplementation. https://pmc.ncbi.nlm.nih.gov/articles/PMC13258800/
  6. Coenzyme Q10 — Drugs and Lactation Database (LactMed). https://www.ncbi.nlm.nih.gov/books/NBK501788/

Methodology: Subpages evidence-led supplement pipeline v1

Ingredient overview: Ubidecarenone